文献速递冠心病心力衰竭与心肌病

心肌梗死后巨噬细胞特异性环状RNA circHIPK2与炎症及纤维化的关系

Macrophage-specific circular RNA circHIPK2, inflammation, and fibrosis after myocardial infarction.
PubMed 文献 · Eur Heart J · 2026-01-01

本研究探讨环状RNA circHIPK2在心肌梗死后心脏巨噬细胞极化中的作用。研究发现circHIPK2在炎症性心脏巨噬细胞中上调,通过与G3BP1结合促进应激颗粒形成,启动下游炎症级联。巨噬细胞特异性抑制circHIPK2可改善小鼠心肌梗死后心功能、重塑炎症环境并减轻纤维化进展。

要点

  • circHIPK2在心肌梗死后炎症性心脏巨噬细胞中上调,调控巨噬细胞极化。
  • 抑制circHIPK2可改善小鼠心肌梗死后心功能并减轻纤维化。
  • 沉默人巨噬细胞circHIPK2对已建立的心力衰竭具有潜在治疗价值。

核心结论

  • 靶向巨噬细胞circHIPK2可能成为治疗炎症性心脏疾病和心力衰竭的新策略。

研究设计与样本

  • 本研究为实验研究,采用体外siRNA和过表达载体调控circHIPK2水平。
  • 建立小鼠心肌梗死模型,通过AAV9介导的shRNA递送实现巨噬细胞靶向抑制circHIPK2。
  • 利用心力衰竭患者活体心肌切片与人iPSC来源巨噬细胞建立体外共培养平台。

主要发现

  • circHIPK2与结合伴侣G3BP1相互作用,促进巨噬细胞应激颗粒形成。
  • circHIPK2与G3BP1的相互作用启动下游炎症级联反应。
  • 抑制circHIPK2可抑制炎症信号传导并减少促炎细胞因子分泌。
  • 小鼠心肌梗死模型中巨噬细胞特异性抑制circHIPK2可改善心功能、重塑炎症环境并减轻纤维化进展。
  • 在人巨噬细胞中沉默circHIPK2对已建立的心力衰竭显示出促进有益心脏愈合的治疗潜力。

临床怎么用

  • circHIPK2可作为心肌梗死后巨噬细胞极化调控的潜在干预靶点。
  • 靶向免疫细胞的RNA疗法在心肌梗死治疗中具有开发前景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Cardiac remodelling following MI is intricately linked to macrophage polarization dynamics, yet the underlying mechanisms remain incompletely elucidated. In this study, circHIPK2, a novel circRNA, was identified as being upregulated in inflammatory cardiac macrophages following MI. Its expression correlated with post-MI inflammation dynamics, suggesting a regulatory role in macrophage polarization. It was hypothesized that circHIPK2 functions as a molecular switch of macrophage polarization during MI progression. METHODS: To test this hypothesis, circHIPK2 levels were modulated in vitro using siRNA and overexpression vectors. A murine MI model with macrophage-targeted inhibition of circHIPK2 through AAV9-mediated shRNA delivery was employed. Cardiac function was evaluated using echocardiography, histology, and PET imaging. An ex vivo co-culture platform incorporating living myocardial slices from heart failure patients and circHIPK2-modulated human iPSC-derived macrophages was established to explore a translational potential. RESULTS: CircHIPK2 interacts with its binding partner G3BP1 to promote stress granule formation in macrophages. This interaction initiates a downstream inflammatory cascade, highlighting its role in immune regulation. Inhibition of circHIPK2 suppressed inflammatory signalling and reduced pro-inflammatory cytokine secretion. In a mouse model of MI, macrophage-specific inhibition of circHIPK2 improved cardiac function, reshaped the inflammatory environment, and attenuated fibrosis progression. Silencing circHIPK2 in human macrophages demonstrated therapeutic potential in established heart failure, promoting beneficial cardiac healing. CONCLUSIONS: Targeting circHIPK2 in macrophages may represent a promising therapeutic strategy for treating inflammatory cardiac conditions and heart failure, potentially leading to the development of RNA-based therapies targeting immune cells in MI treatment.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Jung, Schmidt, Sansonetti, et al. Macrophage-specific circular RNA circHIPK2, inflammation, and fibrosis after myocardial infarction. Eur Heart J. 2026. PMID: 41667113. doi:10.1093/eurheartj/ehaf1116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。